148 related articles for article (PubMed ID: 18330696)
1. The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study.
Cust AE; Stocks T; Lukanova A; Lundin E; Hallmans G; Kaaks R; Jonsson H; Stattin P
Breast Cancer Res Treat; 2009 Feb; 113(3):567-76. PubMed ID: 18330696
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.
Stocks T; Lukanova A; Rinaldi S; Biessy C; Dossus L; Lindahl B; Hallmans G; Kaaks R; Stattin P
Int J Cancer; 2007 Jun; 120(12):2678-86. PubMed ID: 17278097
[TBL] [Abstract][Full Text] [Related]
3. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
Cairat M; Rinaldi S; Navionis AS; Romieu I; Biessy C; Viallon V; Olsen A; Tjønneland A; Fournier A; Severi G; Kvaskoff M; Fortner RT; Kaaks R; Aleksandrova K; Schulze MB; Masala G; Tumino R; Sieri S; Grasso C; Mattiello A; Gram IT; Olsen KS; Agudo A; Etxezarreta PA; Sánchez MJ; Santiuste C; Barricarte A; Monninkhof E; Hiensch AE; Muller D; Merritt MA; Travis RC; Weiderpass E; Gunter MJ; Dossus L
BMC Med; 2022 Apr; 20(1):118. PubMed ID: 35430795
[TBL] [Abstract][Full Text] [Related]
4. Plasma leptin levels and risk of breast cancer in premenopausal women.
Harris HR; Tworoger SS; Hankinson SE; Rosner BA; Michels KB
Cancer Prev Res (Phila); 2011 Sep; 4(9):1449-56. PubMed ID: 21680707
[TBL] [Abstract][Full Text] [Related]
5. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
[TBL] [Abstract][Full Text] [Related]
6. Components of the metabolic syndrome and colorectal cancer risk; a prospective study.
Stocks T; Lukanova A; Johansson M; Rinaldi S; Palmqvist R; Hallmans G; Kaaks R; Stattin P
Int J Obes (Lond); 2008 Feb; 32(2):304-14. PubMed ID: 17878894
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of leptin, adiposity and breast cancer risk.
Wu MH; Chou YC; Chou WY; Hsu GC; Chu CH; Yu CP; Yu JC; Sun CA
Br J Cancer; 2009 Feb; 100(4):578-82. PubMed ID: 19223908
[TBL] [Abstract][Full Text] [Related]
9. Plasma leptin and breast cancer risk: a prospective study in northern Sweden.
Stattin P; Söderberg S; Biessy C; Lenner P; Hallmans G; Kaaks R; Olsson T
Breast Cancer Res Treat; 2004 Aug; 86(3):191-6. PubMed ID: 15567935
[TBL] [Abstract][Full Text] [Related]
10. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
11. Plasma adipokines and endometriosis risk: a prospective nested case-control investigation from the Nurses' Health Study II.
Shah DK; Correia KF; Harris HR; Missmer SA
Hum Reprod; 2013 Feb; 28(2):315-21. PubMed ID: 23188112
[TBL] [Abstract][Full Text] [Related]
12. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin, resistin and leptin in paediatric chronic renal failure: correlation with auxological and endocrine profiles.
Maggio MC; Montaperto D; Maringhini S; Corrado C; Gucciardino E; Corsello G
J Nephrol; 2014 Jun; 27(3):275-9. PubMed ID: 24449263
[TBL] [Abstract][Full Text] [Related]
14. Markers of insulin resistance and sex steroid hormone activity in relation to breast cancer risk: a prospective analysis of abdominal adiposity, sebum production, and hirsutism (Italy).
Muti P; Stanulla M; Micheli A; Krogh V; Freudenheim JL; Yang J; Schünemann HJ; Trevisan M; Berrino F
Cancer Causes Control; 2000 Sep; 11(8):721-30. PubMed ID: 11065009
[TBL] [Abstract][Full Text] [Related]
15. High-sensitivity C-reactive protein, hemoglobin A1c and breast cancer risk: a nested case-control study from Alberta's Tomorrow Project cohort.
Price TR; Friedenreich CM; Robson PJ; Li H; Brenner DR
Cancer Causes Control; 2020 Dec; 31(12):1057-1068. PubMed ID: 32959132
[TBL] [Abstract][Full Text] [Related]
16. Obesity, mammography use and accuracy, and advanced breast cancer risk.
Kerlikowske K; Walker R; Miglioretti DL; Desai A; Ballard-Barbash R; Buist DS
J Natl Cancer Inst; 2008 Dec; 100(23):1724-33. PubMed ID: 19033562
[TBL] [Abstract][Full Text] [Related]
17. Plasma carotenoids and breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.
Wang Y; Gapstur SM; Gaudet MM; Furtado JD; Campos H; McCullough ML
Cancer Causes Control; 2015 Sep; 26(9):1233-44. PubMed ID: 26081425
[TBL] [Abstract][Full Text] [Related]
18. Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.
Gross AL; Newschaffer CJ; Hoffman-Bolton J; Rifai N; Visvanathan K
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1319-24. PubMed ID: 23651666
[TBL] [Abstract][Full Text] [Related]
19. Changes in Body Mass Index, Leptin, and Leptin Receptor Polymorphisms and Breast Cancer Risk.
Liu CR; Li Q; Hou C; Li H; Shuai P; Zhao M; Zhong XR; Xu ZP; Li JY
DNA Cell Biol; 2018 Mar; 37(3):182-188. PubMed ID: 29336592
[TBL] [Abstract][Full Text] [Related]
20. 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1.
Amir E; Cecchini RS; Ganz PA; Costantino JP; Beddows S; Hood N; Goodwin PJ
Breast Cancer Res Treat; 2012 Jun; 133(3):1077-88. PubMed ID: 22415479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
